The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study

• Rolf Jorde ,

  * E-mail: rolf.jorde@unn.no

  Affiliations Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway, The School of Population Health, University of Auckland, Auckland, New Zealand

  ⨯
• Henrik Schirmer,

  Affiliation Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway

  ⨯
• Tom Wilsgaard,

  Affiliation Epidemiology of Chronic Diseases Research Group, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway

  ⨯
• Ellisiv Bøgeberg Mathiesen,

  Affiliations Brain and Circulation Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway, Department of Neurology and Neurophysiology, University Hospital of North Norway, Tromsø, Norway

  ⨯
• Inger Njølstad,

  Affiliation Epidemiology of Chronic Diseases Research Group, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway

  ⨯
• Maja-Lisa Løchen,

  Affiliation Epidemiology of Chronic Diseases Research Group, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway

  ⨯
• Ragnar Martin Joakimsen,

  Affiliations Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

  ⨯
• Guri Grimnes

  Affiliations Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

  ⨯